Velorum-PPX
Erythropoietic Protoporphyria (EPP) / X‑linked Protoporphyria (XLP)
PreclinicalActive
Key Facts
Indication
Erythropoietic Protoporphyria (EPP) / X‑linked Protoporphyria (XLP)
Phase
Preclinical
Status
Active
Company
About Velorum Therapeutics
Innovative heme‑focused biologics for rare porphyrias and heme‑driven diseases.
View full company profile